PE20010648A1 - Derivados de quinolin-4-ilo amino u oxi - Google Patents
Derivados de quinolin-4-ilo amino u oxiInfo
- Publication number
- PE20010648A1 PE20010648A1 PE2000001024A PE0010242000A PE20010648A1 PE 20010648 A1 PE20010648 A1 PE 20010648A1 PE 2000001024 A PE2000001024 A PE 2000001024A PE 0010242000 A PE0010242000 A PE 0010242000A PE 20010648 A1 PE20010648 A1 PE 20010648A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- quinolin
- phenyl
- amino
- ilamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A QUINOLIN-1-IL SUSTITUIDOS, DE FORMULA I, DONDE R1 ES H, ALQUILO, ALCOXILO, OH, AMINO, NITRO, CIANO, ALQUIL-AMINO, DIALQUILAMINO, HALOGENO, ENTRE OTROS; R2 ES FENILO OPCIONALMENTE SUSTITUIDO CON ALQUILO, ALCOXILO, HALOGENO, TRIFLUOROMETILO, AMINO, ALQUILAMINO, ENTRE OTROS; R3 Y R4 SON H, ALQUILO; R3 ES H, ALQUILO, CH2OH, CH2NR6R7; R6 Y R7 SON H, ALQUILO, (CH2)n-FENILO, CICLOALQUILO, (CH2)m-MORFOLINO, O JUNTO CON N FORMAN UN ANILLO SATURADO C4-C6; n ES 0-3; m ES 2-3; X ES NR8, O; X Y R5 SON N(CH2)2-, X Y R3 SON N(CH2)3; R8 ES H, ALQUILO, EXCEPTO LOS COMPUESTOS (6-CLORO-2-FENIL-4-QUINOLINIL)-(+)-2-AMINOBUTANOL, (6-METIL-2-FENIL-4-QUINOLINIL)-(+)-2-AMINOBUTANOL, ENTRE OTROS. SON COMPUESTOS PREFERIDOS 2-{2-(3,4-DIHIDRO-1H-ISOQUINOLIN-2-IL)-QUINOLIN-4-ILAMINO)-ETANOL, (RS)-1-AMINO-3-(2-p-TOLIL-QUINOLIN-4-ILAMINO)PROPAN-2-OL, (RS)-1-(7-METOXI-2-FENIL-QUINOLIN-4-ILOXI)-3-METILAMINO-PROPAN-2-OL, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN BLOQUEADOR SELECTIVO DEL RECEPTOR N-METIL-D-ASPARTATO (NMDA) Y PUEDE SER UTIL PARA EL TRATAMIENTO DE FORMAS AGUDAS DE NEURODEGENERACION, ALZHEIMER, PARKINSON, HUNTINGTON, ESCLEROSIS LATERAL AMIOTROFICA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99119539 | 1999-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010648A1 true PE20010648A1 (es) | 2001-06-13 |
Family
ID=8239107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001024A PE20010648A1 (es) | 1999-10-01 | 2000-09-28 | Derivados de quinolin-4-ilo amino u oxi |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6440995B1 (es) |
| JP (1) | JP3523174B2 (es) |
| KR (1) | KR100398561B1 (es) |
| CN (1) | CN1181059C (es) |
| AR (1) | AR025882A1 (es) |
| AT (1) | ATE281436T1 (es) |
| AU (1) | AU774363B2 (es) |
| BR (1) | BR0004548A (es) |
| CA (1) | CA2321324A1 (es) |
| CO (1) | CO5200789A1 (es) |
| CZ (1) | CZ20003575A3 (es) |
| DE (1) | DE60015471T2 (es) |
| ES (1) | ES2230017T3 (es) |
| HR (1) | HRP20000639A2 (es) |
| HU (1) | HUP0003861A3 (es) |
| ID (1) | ID27525A (es) |
| IL (1) | IL138777A0 (es) |
| MA (1) | MA26752A1 (es) |
| NO (1) | NO20004892L (es) |
| NZ (1) | NZ507141A (es) |
| PE (1) | PE20010648A1 (es) |
| PL (1) | PL342876A1 (es) |
| PT (1) | PT1088818E (es) |
| SG (1) | SG164268A1 (es) |
| TR (1) | TR200002831A3 (es) |
| ZA (1) | ZA200005239B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6831087B2 (en) * | 2001-11-09 | 2004-12-14 | Hoffmann-La Roche Inc. | Pyridine substituted isoquinoline derivatives |
| WO2003068748A1 (en) * | 2002-02-13 | 2003-08-21 | F. Hoffmann-La Roche Ag | Novel pyridine- and quinoline-derivatives |
| JP2008506695A (ja) * | 2004-07-13 | 2008-03-06 | グラクソ グループ リミテッド | 抗細菌剤 |
| WO2009042907A1 (en) * | 2007-09-27 | 2009-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| JP6527534B2 (ja) * | 2014-06-16 | 2019-06-05 | ファンダシオン パラ ラ インベスティガシオン メディカ アプリカダＦｕｎｄａｃｉｏｎ Ｐａｒａ Ｌａ Ｉｎｖｅｓｔｉｇａｓｉｏｎ Ｍｅｄｉｃａ Ａｐｌｉｃａｄａ | ヒストンメチルトランスフェラーゼ及びｄｎａメチルトランスフェラーゼの二重阻害剤としての新規化合物 |
| CN107427506A (zh) * | 2014-10-14 | 2017-12-01 | 拉霍拉敏感及免疫学研究所 | 低分子量蛋白酪氨酸磷酸酶的抑制剂及其用途 |
| KR20170074178A (ko) * | 2015-12-21 | 2017-06-29 | 제이엔씨 주식회사 | 중합성 액정 화합물, 조성물, 그 액정 중합막류 및 이들의 용도 |
| CN105646462B (zh) * | 2016-01-19 | 2019-04-05 | 河南大学 | 芸香宁碱衍生物、其制备方法及应用 |
| US11066420B2 (en) | 2017-05-01 | 2021-07-20 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE440008C (de) | 1924-03-29 | 1927-05-04 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von Chinolinderivaten |
| US4560692A (en) | 1984-07-18 | 1985-12-24 | Hoffmann-La Roche Inc. | 4-Piperidino-2-phenylquinolines |
| GB9125515D0 (en) | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| US5441963A (en) | 1991-12-20 | 1995-08-15 | Merrell Dow Pharmaceuticals | Potentiation of NMDA antagonists |
-
2000
- 2000-09-11 US US09/658,934 patent/US6440995B1/en not_active Expired - Fee Related
- 2000-09-26 AT AT00120890T patent/ATE281436T1/de not_active IP Right Cessation
- 2000-09-26 DE DE60015471T patent/DE60015471T2/de not_active Expired - Fee Related
- 2000-09-26 ES ES00120890T patent/ES2230017T3/es not_active Expired - Lifetime
- 2000-09-26 MA MA26068A patent/MA26752A1/fr unknown
- 2000-09-26 NZ NZ507141A patent/NZ507141A/en unknown
- 2000-09-26 PT PT00120890T patent/PT1088818E/pt unknown
- 2000-09-27 SG SG200005551-7A patent/SG164268A1/en unknown
- 2000-09-27 CA CA002321324A patent/CA2321324A1/en not_active Abandoned
- 2000-09-27 AU AU61324/00A patent/AU774363B2/en not_active Ceased
- 2000-09-27 CO CO00073351A patent/CO5200789A1/es not_active Application Discontinuation
- 2000-09-27 CZ CZ20003575A patent/CZ20003575A3/cs unknown
- 2000-09-28 CN CNB001292013A patent/CN1181059C/zh not_active Expired - Fee Related
- 2000-09-28 HR HR20000639A patent/HRP20000639A2/hr not_active Application Discontinuation
- 2000-09-28 IL IL13877700A patent/IL138777A0/xx unknown
- 2000-09-28 ZA ZA200005239A patent/ZA200005239B/xx unknown
- 2000-09-28 AR ARP000105102A patent/AR025882A1/es not_active Application Discontinuation
- 2000-09-28 PE PE2000001024A patent/PE20010648A1/es not_active Application Discontinuation
- 2000-09-29 NO NO20004892A patent/NO20004892L/no unknown
- 2000-09-29 KR KR10-2000-0057259A patent/KR100398561B1/ko not_active IP Right Cessation
- 2000-09-29 JP JP2000298078A patent/JP3523174B2/ja not_active Expired - Fee Related
- 2000-09-29 TR TR2000/02831A patent/TR200002831A3/tr unknown
- 2000-09-29 ID IDP20000849D patent/ID27525A/id unknown
- 2000-09-29 HU HU0003861A patent/HUP0003861A3/hu unknown
- 2000-09-29 BR BR0004548-9A patent/BR0004548A/pt not_active IP Right Cessation
- 2000-09-29 PL PL00342876A patent/PL342876A1/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID27525A (id) | 2001-04-12 |
| CN1181059C (zh) | 2004-12-22 |
| CO5200789A1 (es) | 2002-09-27 |
| AR025882A1 (es) | 2002-12-18 |
| JP2001097952A (ja) | 2001-04-10 |
| NZ507141A (en) | 2002-05-31 |
| TR200002831A2 (tr) | 2001-04-20 |
| DE60015471D1 (de) | 2004-12-09 |
| US6440995B1 (en) | 2002-08-27 |
| HUP0003861A3 (en) | 2002-09-30 |
| ES2230017T3 (es) | 2005-05-01 |
| CN1290698A (zh) | 2001-04-11 |
| AU6132400A (en) | 2001-04-05 |
| HRP20000639A2 (en) | 2001-06-30 |
| BR0004548A (pt) | 2001-05-29 |
| DE60015471T2 (de) | 2005-10-27 |
| PT1088818E (pt) | 2005-03-31 |
| NO20004892D0 (no) | 2000-09-29 |
| HU0003861D0 (en) | 2000-12-28 |
| MA26752A1 (fr) | 2004-12-20 |
| JP3523174B2 (ja) | 2004-04-26 |
| TR200002831A3 (tr) | 2001-04-20 |
| SG164268A1 (en) | 2010-09-29 |
| ATE281436T1 (de) | 2004-11-15 |
| ZA200005239B (en) | 2001-04-16 |
| NO20004892L (no) | 2001-04-02 |
| CA2321324A1 (en) | 2001-04-01 |
| PL342876A1 (en) | 2001-04-09 |
| KR20010050738A (ko) | 2001-06-15 |
| AU774363B2 (en) | 2004-06-24 |
| CZ20003575A3 (cs) | 2001-11-14 |
| KR100398561B1 (ko) | 2003-09-19 |
| HUP0003861A2 (hu) | 2001-10-28 |
| IL138777A0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020514A1 (es) | Aminas heterociclicas y fenilazacicloalcanos sustituidos para el tratamiento del sindrome de piernas inquietas | |
| PE20050482A1 (es) | Derivados de dihidrobenzofuranilo alcanamida | |
| PE20020753A1 (es) | Heteroaromaticos fusionados como activadores de la glucoquinasa | |
| PE20070007A1 (es) | Metodos para sintetizar derivados de 6-alquilaminoquinolina | |
| SE8106642L (sv) | Piperazinylbensoheterocykliska foreningar och forfarande for framstellning derav | |
| PE20020917A1 (es) | Derivados de imidazol como bloqueadores del receptor n-metil-d-aspartato | |
| PE20001467A1 (es) | Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina | |
| PE20071223A1 (es) | Procedimiento de preparacion de derivados de acil-amino-alquilen-amida | |
| DK0595851T3 (da) | Fremgangsmåde til fremstilling af sertralin-mellemprodukter | |
| PE20030268A1 (es) | Compuestos de pirazina como ligandos del receptor de 5-ht | |
| AR018917A1 (es) | Compuestos derivados de adenosina que son agonistas en el receptor adenosina a1, proceso para su preparacion, composiciones farmaceuticas que los contienen. | |
| PE20061305A1 (es) | Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas | |
| PE20010648A1 (es) | Derivados de quinolin-4-ilo amino u oxi | |
| DE69523159D1 (de) | Sulfonamidderivate von azolonen als anti-helicobacter-mittel | |
| PE20010964A1 (es) | Derivados de tiazolilamida | |
| ES2054309T3 (es) | Compuestos de urea sustituida y su preparacion y uso. | |
| PE20020063A1 (es) | Bis-arilsulfonas como ligandos del receptor de 5-ht | |
| PE20011212A1 (es) | Compuestos para el tratamiento de la fibromialgia y el sindrome de fatiga cronica | |
| PE20001084A1 (es) | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas | |
| KR840006633A (ko) | 벤족사졸리논 유도체의 제조방법 | |
| PE20020253A1 (es) | Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos | |
| PT97800A (pt) | Processo para a preparacao duma composicao repelente de insectos e acaros contendo derivados de morfolino-ureia | |
| DE68905283T2 (de) | Alpha,Alpha disubstituierte N-Cycloalkylalkyl-Benzylamine, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und ihre Zwischenprodukte bei der Herstellung. | |
| PE20020906A1 (es) | Inhibidores de peptido-deformilasa | |
| AR033300A1 (es) | Compuestos de cefem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |